These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33604679)

  • 21. Rivaroxaban Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Hypertension.
    Imano H; Kato R; Nomura A; Tamura M; Yamaguchi Y; Ijiri Y; Wu H; Nakano T; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M; Hayashi T
    Biol Pharm Bull; 2021 May; 44(5):669-677. PubMed ID: 33612567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.
    Vanderpool RR; Gorelova A; Ma Y; Alhamaydeh M; Baust J; Shiva S; Tofovic SP; Hu J; Nouraie SM; Gladwin MT; Sharifi-Sanjani M; Al Ghouleh I
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maxingxiongting mixture attenuates hypoxia pulmonary arterial hypertension to improve right ventricular hypertrophy by inhibiting the rho-kinase signaling pathway.
    An X; Li S; Weng X; Wang X; Wu H; Zhang X; Gao J; Yang R; Peng B; Li S; Weng X; Wang X; Zhang X; Gao J
    J Tradit Chin Med; 2020 Dec; 40(6):992-998. PubMed ID: 33258351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of connective tissue growth factor and its down-regulation by simvastatin administration in pulmonary hypertensive rats].
    Liu B; Wang XM; Zhou TF; Hua YM; Liu HM; Wei L; Qiao LN; Wang XQ; Zhao SS; Shi K
    Zhonghua Er Ke Za Zhi; 2008 May; 46(5):359-65. PubMed ID: 19099753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats.
    He J; Lu Y; Song X; Gong X; Li Y
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31763669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The siRNA-mediated knockdown of AP-1 restores the function of the pulmonary artery and the right ventricle by reducing perivascular and interstitial fibrosis and key molecular players in cardiopulmonary disease.
    Comarița IK; Tanko G; Anghelache IL; Georgescu A
    J Transl Med; 2024 Feb; 22(1):137. PubMed ID: 38317144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi‑omics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.
    Kobayashi T; Kim JD; Naito A; Yanagisawa A; Jujo-Sanada T; Kasuya Y; Nakagawa Y; Sakao S; Tatsumi K; Suzuki T
    Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35315498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.
    Kameny RJ; He Y; Zhu T; Gong W; Raff GW; Chapin CJ; Datar SA; Boehme JT; Hata A; Fineman JR
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H847-H854. PubMed ID: 29906222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early treatment with hepatocyte growth factor improves pulmonary artery and right ventricular remodeling in rats with pulmonary artery hypertension by modulating cytokines expression].
    Wang X; Wang Y; Rong S; Ma H
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):427-32. PubMed ID: 25200042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension.
    Dai Y; Chen X; Song X; Chen X; Ma W; Lin J; Wu H; Hu X; Zhou Y; Zhang H; Liao Y; Qiu Z; Zhou Z
    J Am Coll Cardiol; 2019 May; 73(20):2567-2580. PubMed ID: 31118151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.
    Sugiyama A; Kaisho M; Okada M; Otani K; Yamawaki H
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
    Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
    Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
    Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
    J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.